A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is application/pdf.
2022-RA-958-ESGO Invasive stratified mucin-producing intraepithelial lesion (iSMILE) a rare entity of cervical cancer
2022
Cervical cancer
unpublished
Preserved Fulltext
Methodology Eligible patients had FIGO 2009 stage IB2-IIIB cervical cancer with no or only limited (£5 mm) vaginal involvement. Comprehensive assessment of vaginal changes was done before treatment, at 4-6 weeks and 3, 6, 12 and 24 months thereafter using CTCAE v3.0 and additional assessments. PRO were assessed at the same timepoints using validated Quality of Life (EORTC QLQ-C30 and CX24) and sexual questionnaires. Statistical methods included generalized linear mixed model analysis and Spearman's rho correlation coefficients.
doi:10.1136/ijgc-2022-esgo.75
fatcat:gk4art64snelrgu42rgofgd2ve